Abstract:
An object of the present invention is to provide a novel bisbenzotriazolylphenol compound having a UV absorving effect. The bisbenzotriazolylphenol compound of the invention is represented by the formula ##STR1## wherein A is a direct bond or represents a C.sub.1-6 alkylene group, a --C(CH.sub.3).sub.2 -- group, a --C(C.sub.2 H.sub.5)(CH.sub.3)-- group, a --O-- group or a --NH-- group, R.sup.1 and R.sup.3 are the same or different and each represent a hydrogen atom, a C.sub.1-4 alkyl group, an aryl group, a C.sub.1-4 alkoxy group or a halogen atom, and R.sup.2 and R.sup.4 are the same or different and each represent a hydroxyl group or a C.sub.1-12 straight- or branched-chain hydroxyalkyl group.
Abstract:
A superlattice APD includes light absorption layer for generating carriers by absorbing light, a multiplication layer for multiplying the carriers, and a pair of electrodes for driving the carriers. The multiplication layer includes a superlattice structure with a well layer less than 10 nm in thickness and a barrier layer more than 10 nm and less than 20 nm in thickness deposited in alternate layers.
Abstract:
A semiconductor optical switch and an optical switch array for use in an optical logic circuit, photonic switching, OEIC, etc., wherein a light amplifying means is provided on a bypass waveguide that connects a plurality of optical waveguides, thereby enabling improvement of the light crosstalk and the light propagation loss. In particular, according to the arrangement of the present invention that a light amplifying means is provided in addition to the deflecting portion, no noise component is amplified and therefore the SN ratio is markedly increased.
Abstract:
Disclosed is a process for concentrating aqueous urea solutions in which an aqueous urea solution is allowed to flow as a falling film in countercurrent contact with a stream of hot inert gas to concentrate it to 95-99% by weight and the aqueous urea solution so concentrated is then passed through a packed zone in cocurrent contact with a stream of hot inert gas to concentrate it to not less than 99.5% by weight.
Abstract:
A method for producing an optical fiber comprises (i) the step of depositing a barrier layer on the inner wall surface of a glass tube by the CVD (chemical vapor deposition) process, said barrier layer being capable of preventing the diffusion of impurities and being made of high-silica glass which has a refractive index that is substantially equal to that of the glass tube and which contains at least one substance for lowering the refractive index of silica and at least one substance for raising the refractive index of silica, (ii) the step of depositing a glass film of desired refractive index on the barrier layer by the CVD process, (iii) the step of heating and collapsing the resultant glass tube into a composite rod or the so-called optical fiber preform, and (iv) the step of heating and drawing said optical fiber preform into the optical fiber, whereby the optical fiber which has the impurity diffusion-preventing layer between the core and the outside glass layer can be easily produced.
Abstract:
A C-shaped resilient housing for encompassing at least three sides of an escalator belt and biasing a solution bearing pad into continuous abutment with the escalator belt. Ribs interior to the housing and flanges exterior to the rear of the housing may be included to hold the pad in place.
Abstract:
A monoclonal antibody that binds to an extracellular domain of human receptor-type protein tyrosine phosphatase σ (human PTPRS), or a fragment including an antigen-binding region thereof.
Abstract:
A monoclonal antibody that binds to an extracellular domain of human receptor-type protein tyrosine phosphatase σ (human PTPRS), or a fragment including an antigen-binding region thereof.
Abstract:
An antibody binding to IPC was obtained by using an animal cell in which a cell membrane protein associatable with ILT7 was co-expressed as an immunogen. The antibody of the invention has a high specificity which allows immunological distinction between other ILT family molecules and ILT7. The anti-ILT7 antibody of the invention bound to IPC and inhibited the activity thereof. With the anti-ILT7 antibody of the invention, the IPC activity can be inhibited and an interferon-related disease can be treated or prevented. ILT7 expression is maintained even in IPC in the presence of IFNα. Therefore, an inhibitory action of IPC activity by the anti-ILT7 antibody can be expected even in an autoimmune disease patient with an increased production of IFNα.
Abstract:
An antibody binding to IPC was obtained by using an animal cell in which a cell membrane protein associatable with ILT7 was co-expressed as an immunogen. The antibody of the invention has a high specificity which allows immunological distinction between other ILT family molecules and ILT7. The anti-ILT7 antibody of the invention bound to IPC and inhibited the activity thereof. With the anti-ILT7 antibody of the invention, the IPC activity can be inhibited and an interferon-related disease can be treated or prevented. ILT7 expression is maintained even in IPC in the presence of IFNα. Therefore, an inhibitory action of IPC activity by the anti-ILT7 antibody can be expected even in an autoimmune disease patient with an increased production of IFNα.